Patents by Inventor Lawrence Lum

Lawrence Lum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120102581
    Abstract: Inhibitors of luciferase enzymes are disclosed and find use in multiplexed assays using multiple luciferases and multiple inhibitors, in both in vitro and in vivo embodiments.
    Type: Application
    Filed: October 20, 2010
    Publication date: April 26, 2012
    Inventors: Lawrence Lum, Ozlem Kulak
  • Publication number: 20110136813
    Abstract: The present invention generally relates to protein signalling. In particular, compounds that inhibit the Wnt protein signalling pathway are disclosed. Such compounds may be used in the treatment of Wnt protein signalling-related diseases and conditions such as cancer, degenerative diseases, type II diabetes and osteopetrosis.
    Type: Application
    Filed: May 27, 2009
    Publication date: June 9, 2011
    Inventors: Lawrence Lum, Michael G. Roth, Baozhi Chen, Chuo Chen, Michael E. Dodge, Wei Tang
  • Publication number: 20070110733
    Abstract: This invention provides compositions of matter, articles of manufacture and methods for delivering and/or affixing a stem cell to a target tissue. This invention also provides related nucleic acids, vectors, cell, methods of production, and kits.
    Type: Application
    Filed: April 23, 2003
    Publication date: May 17, 2007
    Inventors: Lawrence Lum, Randall Lee
  • Publication number: 20060034767
    Abstract: The present invention provides a method for tracking and targeting cells in viva. In particular, cells are isolated purified and armed with bispecific antibodies which are directly labeled with a detectable marker, or a second antibody specific for a region of the bispecific antibody is labeled with a detectable marker. The bispecific antibody is specific for a surface antigen of the cell and the second specificity of the specific antigen is for an antigen expressed on cells of tissues, organs or tumors. The armed and labeled cells can be tracked starting from the point of introduction into the animal until the cell reaches the target of interest by phenotyping cells from patient samples, obtained at different time intervals and locations, post-infusion. The isolated and purified cells are useful in any functional assay.
    Type: Application
    Filed: July 3, 2003
    Publication date: February 16, 2006
    Inventors: Lawrence Lum, Randall Lee, Nicola Kouttab
  • Publication number: 20060018897
    Abstract: The present invention provides compositions and methods for targeting stem cells to injured cardiac tissue.
    Type: Application
    Filed: June 28, 2005
    Publication date: January 26, 2006
    Applicant: TransTarget Inc.
    Inventors: Randall Lee, James Larrick, Lawrence Lum